Chemoinformaics analysis of 11-beta-H,13-dihydrosantamarine
Molecular Weight | 250.338 | nRot | 0 |
Heavy Atom Molecular Weight | 228.162 | nRig | 16 |
Exact Molecular Weight | 250.157 | nRing | 3 |
Solubility: LogS | -2.866 | nHRing | 1 |
Solubility: LogP | 2.992 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 42.1254 |
nHD | 1 | BPOL | 24.6746 |
QED | 0.53 |
Synth | 4.441 |
Natural Product Likeliness | 3.499 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.017 |
HIA | 0.102 |
CACO-2 | -4.523 |
MDCK | 0.0000336 |
BBB | 0.852 |
PPB | 0.616318 |
VDSS | 1.104 |
FU | 0.351398 |
CYP1A2-inh | 0.113 |
CYP1A2-sub | 0.319 |
CYP2c19-inh | 0.027 |
CYP2c19-sub | 0.673 |
CYP2c9-inh | 0.02 |
CYP2c9-sub | 0.214 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.438 |
CYP3a4-inh | 0.23 |
CYP3a4-sub | 0.27 |
CL | 18.503 |
T12 | 0.1 |
hERG | 0.017 |
Ames | 0.011 |
ROA | 0.643 |
SkinSen | 0.066 |
Carcinogencity | 0.086 |
EI | 0.018 |
Respiratory | 0.821 |
NR-Aromatase | 0.006 |
Antiviral | Yes |
Prediction | 0.873418 |